...
机译:结构引导的脂蛋白相关磷脂酶A2新型,有效和口服生物可利用的抑制剂
CAS Key Laboratory of Receptor Research State Key Laboratory of Drug Research Drug Discovery and Design Center Shanghai Institute of Materia Medica Chinese Academy of Sciences (CAS) Shanghai 201203 China;
CAS Key Laboratory of Receptor Research State Key Laboratory of Drug Research Drug Discovery and Design Center Shanghai Institute of Materia Medica Chinese Academy of Sciences (CAS) Shanghai 201203 China;
CAS Key Laboratory of Receptor Research State Key Laboratory of Drug Research Drug Discovery and Design Center Shanghai Institute of Materia Medica Chinese Academy of Sciences (CAS) Shanghai 201203 China;
CAS Key Laboratory of Receptor Research State Key Laboratory of Drug Research Drug Discovery and Design Center Shanghai Institute of Materia Medica Chinese Academy of Sciences (CAS) Shanghai 201203 China;
CAS Key Laboratory of Receptor Research State Key Laboratory of Drug Research Drug Discovery and Design Center Shanghai Institute of Materia Medica Chinese Academy of Sciences (CAS) Shanghai 201203 China;
CAS Key Laboratory of Receptor Research State Key Laboratory of Drug Research Drug Discovery and Design Center Shanghai Institute of Materia Medica Chinese Academy of Sciences (CAS) Shanghai 201203 China;
CAS Key Laboratory of Receptor Research State Key Laboratory of Drug Research Drug Discovery and Design Center Shanghai Institute of Materia Medica Chinese Academy of Sciences (CAS) Shanghai 201203 China;
机译:结构引导的脂蛋白相关磷脂酶A2新型,有效和口服生物可利用的抑制剂
机译:基于片段的方法开发脂蛋白相关磷脂酶A2(Lp-PLA(2))的口服生物利用内酰胺抑制剂。
机译:潜在和口服活性脂蛋白相关的磷脂酶A(2)(Lp-PLA(2))抑制剂的发现作为糖尿病性黄斑水肿的潜在疗法
机译:磷脂酶A2的有效和选择性的2-氧代咪唑抑制剂作为治疗炎性疾病的新型药剂
机译:脂蛋白相关的磷脂酶A2:利用有效的特异性抑制剂来探索结构功能关系
机译:基于支架跳跃的新型香豆素衍生物作为有效和口服生物利用的BRD4抑制剂的发现
机译:发现有效和口服活性脂蛋白相关的磷脂酶A2(LP-PLA2)抑制剂作为糖尿病黄斑水肿的潜在疗法